Showing results (1-10 of 110) with videos related to
Sort By:
Pageof 11
Drug Discovery Today|September 10, 2011
Pharmacogenetics and cost-effectiveness analysis: a two-way streetKalipso Chalkidou, Michael RawlinsHealth Economics, Policy, and Law|October 20, 2012
Evidence and values: paying for end-of-life drugs in the British NHSKalipso ChalkidouJournal of Comparative Effectiveness Research|November 19, 2013
Interview: Setting up NICE InternationalKalipso ChalkidouIssue Brief (Commonwealth Fund)|July 31, 2009
Comparative effectiveness review within the U.K.'s National Institute for Health and Clinical ExcellenceKalipso ChalkidouGlobalization and Health|October 29, 2013
Sharing the British National Health Service around the world: a self-interested perspectiveKalipso Chalkidou, Jeanette VegaPharmacoeconomics|September 14, 2010
Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and futureKalipso Chalkidou, Tom WalleyHealth Economics, Policy, and Law|January 7, 2012
Reflections on the evolution of health technology assessment in EuropeCorinna Sorenson, Kalipso ChalkidouHealth Economics, Policy, and Law|November 27, 2015
Information will be the key to successful implementationPeter Littlejohns, Kalipso ChalkidouValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2019
Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?Anthony J Culyer, Kalipso ChalkidouValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2017
Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health ServicePeter C Smith, Kalipso ChalkidouPageof 11